Trademarkia Logo

Canada

C$
Trademark Search in Canada
ONCXERNA

View On IC.GC.CA

ONCXERNA
REGISTERED

on 24 Nov 2023

TM5 Status

LIVE/REGISTRATION/Issued and Active

Your registration has been issued and is active. You can now use the TM5 mark.

Last Applicant/ Owned by

ONCXERNA THERAPEUTICS INC.

300 Fifth Avenue, Suite 6040Waltham MA 02451

US

Serial Number

2069939 filed on 3rd Nov 2020

Registration Number

TMA1210542 registered on 24th Nov 2023

Registration expiry Date

3rd Nov 2030

Correspondent Address

GOWLING WLG (CANADA) LLP

SUITE 2600, 160 ELGIN STREETOTTAWA

ONTARIO

CA

K1P1C3

ONCXERNA

Trademark usage description

chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules in th Read More

Classification Information

Class [001]
Chemical, biological, biochemical and biotechnological products and preparations for industrial and scientific purposes, namely, small molecules in the nature of active chemical ingredients for use in the manufacture of pharmaceuticals, biologics for use in pharmaceuticals, nucleic acids, proteins, lipids, polysaccharides, enzymes, antibodies, stem cells for scientific purposes, culture of bacterial microorganisms for laboratory and scientific research; cultures of bacterial microorganisms for laboratory and scientific research; cultures of microorganisms used in the fermentation of silage; protein-based capsids and particles as well as fragments, fractions and derivatives thereof, for scientific and medical research; active chemicals ingredients for use in the manufacture of anti-cancer drugs; active chemical ingredients for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of anti-cancer drugs; protein arrays for diagnosing cancer.

Classification kind code

11

Class [005]
Pharmaceutical preparations, namely, proteins for the treatment and diagnosis of cancer, viral infections and infectious diseases, namely, bacterial skin infections, fungal skin infections, viral skin infections, and parasitic skin infections; diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing, namely, testing and detecting of cancer; diagnostic biomarker reagents for medical purposes; diagnostic agents for medical use, namely, tumor markers in the nature of diagnostic biomarkers for use in assessment of cancer biology for medical use; antigens for medical purposes, namely, pharmaceutical preparations for regulating the immune system; diagnostic reagents for medical use; diagnostic agents for pharmaceutical use, namely, diagnostic preparations for clinical laboratory use.

Classification kind code

11

Class [042]
Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; bioinformatics, chemical and biological analysis.

Classification kind code

11

Mark Details

Serial Number

2069939

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 22
on 5th Apr 2022		Search Recorded
Submitted for opposition 20
on 5th Apr 2022		Examiner's First Report
Submitted for opposition 223
on 5th Apr 2022		Total Provisional Refusal
Submitted for opposition 256
on 11th Oct 2021		Notification of Possible Opposition Sent
Submitted for opposition 48
on 25th Feb 2021		Agent Changed
Submitted for opposition 257
on 10th Dec 2020		Designation Notification - Madrid Protocol
Submitted for opposition 31
on 9th Dec 2020		Formalized
Submitted for opposition 1
on 9th Dec 2020		Created
Submitted for opposition 228
on 3rd Nov 2020		International Registration
Submitted for opposition 30
on 3rd Nov 2020		Filed